Ligand validation:4GYC

LFA: EICOSANE

LFA is a Ligand Of Interest in 4GYC designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4GYC_LFA_A_306	22%	73%	0.197	0.885	0.3	0.73	-	-	0	0	60%	0.6
4GYC_LFA_A_307	14%	73%	0.172	0.792	0.28	0.75	-	-	0	0	60%	0.6
4GYC_LFA_A_310	12%	90%	0.179	0.846	0.19	0.41	-	-	3	0	25%	0.25
4GYC_LFA_A_303	6%	74%	0.188	0.705	0.26	0.73	-	-	0	0	50%	0.5
4GYC_LFA_A_309	2%	89%	0.255	0.687	0.17	0.45	-	-	0	0	25%	0.25
4GYC_LFA_A_304	2%	72%	0.326	0.655	0.27	0.79	-	-	3	0	80%	0.8
4GYC_LFA_A_305	2%	77%	0.247	0.584	0.25	0.67	-	-	0	0	50%	0.5
4GYC_LFA_A_302	1%	84%	0.399	0.651	0.21	0.55	-	-	0	0	35%	0.35
4GYC_LFA_A_308	1%	88%	0.22	0.458	0.18	0.47	-	-	0	0	25%	0.25
3QAP_LFA_A_247	38%	81%	0.09	0.927	0.39	0.43	-	-	0	0	25%	0.25
5JJE_LFA_A_310	38%	83%	0.126	0.861	0.27	0.51	-	-	0	0	80%	0.8
5JJJ_LFA_A_309	33%	78%	0.187	0.956	0.29	0.6	-	-	1	0	50%	0.5
3QDC_LFA_A_248	22%	81%	0.138	0.872	0.34	0.48	-	-	0	0	35%	19.25
5JJF_LFA_A_308	7%	80%	0.275	0.767	0.31	0.52	-	-	6	0	80%	0.8
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	0	75%	0.75
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	0.55
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	0	70%	0.7
4HYJ_LFA_B_302	48%	74%	0.164	0.962	0.2	0.79	-	-	1	0	70%	0.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.